Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

FibroGen, Inc - Common Stock (NQ:FGEN)

0.3380 +0.0105 (+3.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 475,692
Open 0.3325
Bid (Size) 0.3500 (28)
Ask (Size) 0.3530 (10)
Prev. Close 0.3275
Today's Range 0.3200 - 0.3457
52wk Range 0.1800 - 1.740
Shares Outstanding 98,210,168
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For March 17, 2025
Via Benzinga

Performance

YTD
-36.1%
-36.1%
1 Month
+9.1%
+9.1%
3 Month
-29.6%
-29.6%
6 Month
+6.4%
+6.4%
1 Year
-69.8%
-69.8%

More News

Read More
What's going on in today's pre-market session
Via Chartmill
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For FibroGen
Via Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
What's going on in today's session
Via Chartmill
Thursday's session: most active stocks
Via Chartmill
Top movers in Thursday's session
Via Chartmill
Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
Via Benzinga
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program
Via Benzinga
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Why Are Chip Stocks Up Today?
Via InvestorPlace
FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why is Macrogenics (MGNX) Stock Down 28% Today?
Via InvestorPlace
Why Is FibroGen (FGEN) Stock Down 44% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
What's Going On With FibroGen Stock Tuesday?
Via Benzinga
Exposures Product Safety

Frequently Asked Questions

Is FibroGen, Inc - Common Stock publicly traded?
Yes, FibroGen, Inc - Common Stock is publicly traded.
What exchange does FibroGen, Inc - Common Stock trade on?
FibroGen, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for FibroGen, Inc - Common Stock?
The ticker symbol for FibroGen, Inc - Common Stock is FGEN on the Nasdaq Stock Market
What is the current price of FibroGen, Inc - Common Stock?
The current price of FibroGen, Inc - Common Stock is 0.3380
When was FibroGen, Inc - Common Stock last traded?
The last trade of FibroGen, Inc - Common Stock was at 04/30/25 04:00 PM ET
What is the market capitalization of FibroGen, Inc - Common Stock?
The market capitalization of FibroGen, Inc - Common Stock is 33.20M
How many shares of FibroGen, Inc - Common Stock are outstanding?
FibroGen, Inc - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright